Hosted by:

China Chamber of International Commerce（CCOIC）
China Pharmaceutical Industry Research and Development Association (SINO-PhIRDA)
Drug Information Association (DIA)
China Health Insurance Research Association (CHIRA)
Beijing Municipal Bureau of Health
Beijing Food and Drug Administration

Supported by
Embassy of Republic of Poland in Beijing
UK Trade & Investment
Invest in Denmark
Canada British Columbia International Trade and Investment Representative Office
Pharmaceutical Research and Manufacturer Association (PhRMA)
Food and Drug Law Institute（FDLI）
Medical Research Council Technology(MRCT)
Confederation of Indian Industry（CII）
R&D-based Pharmaceutical Association Committee（RDPAC）
PharmAsia News

Agenda
Oct 17th
Registration: All-day
18:30-20:30 CEO Banquet Dinner

Oct 18th
Plenary Meeting
09:00-09:30 Opening Address
09:30-10:10 Keynote Speech: Present Situation and Prospect of Drug Innovation in China
（Sang Guowei -- Vice Chairman of the Standing Committee of the 11thNational People’s Congress，Academician of Chinese Academy of Engineering）
10:10-10:20 Tea Break
10:20-10:45 Keynote Speech: Innovative and Generic Medicinal Products from the Perspective of European Union Regulator
（Grzegorz Cessak -- President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products in Republic of Poland）
10:45-11:10 Keynote Speech: Current Drug Registration Policy and Drug Innovation in China
(Xu Jiaqi –Inspector General of Drugs and Cosmetics Registration Division of CFDA)
11:10-11: 35 Keynote Speech: Relationship between Drug Innovation and Policy
--Foreign Experience
(Timothy R. Franson--Principal in FaegreBD Consulting's Health and Biosciences Sector)
11:35-12:00 Keynote Speech: Drug Biding and Procurement Policy in China
(Zheng Hong--Director General of Department of National Drug Policy and Essential Medicine System, NHFPC)  
12:00-13:30 Buffet Lunch

Afternoon：
Session1：Pharmaceutical Innovation Policy Forum
13:30-14:15Panel: Improving the drug approval system to promote innovative drug into the market.
Host:Wu Zhi’ang--Dean of School of Business Management, Shenyang Pharmaceutical University
Speaker:Xu Jiaqi –Inspector General of Drugs and Cosmetics Registration Division of CFDA
Panelist 1:Shao Rong--Professor, Dean of School of International Pharmaceutical Business of China Pharmaceutical University, doctoral supervisor
Panelist 2:Wang Bo--President of Beijing CHNMED Pharmaceutical Technology Development Co., Ltd
Panelist 3:Cao Guoqing-- Vice President of Jiangsu Hengrui Medicine Co., Ltd
14:20-15:05Panel:Exploration on risk-sharing mechanism of high-cost innovative drugs into health insurance
Host:Yao Hong—Director General of Medical Insurance Division of Ministry of Huamn Resource of Social Security
Speaker:Duan Zhengming--Director of Health Services Administration, Social Security Center of Ministry of Human Resource and Social Security
Panelist 1:Li Jinghu--Vice Sectary-General of China Healthcare Insurance Association
Panelist 2:Liu Junshuai--Director of Social Security Administration of Qingdao
Panelist 3:Zhao Hui--Vice Director of Human Resource and Social Security Department of Jiangsu
15:05-15:15Tea Break
15:15:16:00Panel:Improving the mechanism of drug pricing and promoting medicine innovation
Host：Gu Haoliang—General Manager of Shanghai Sine Pharmaceutical Laboratories Co., Ltd
Speaker:Guo Jianying--Vice Inspector of Price Department of National Development and Reform Commission
Panelist 1:Wang Yong – Chairman of Sanhome Pharmaceuticals
Panelist 2:Senior Official from Pfizer
16:05:16:50Panel:How to enhance the accessibility of innovative drugs through improving drug bidding/ purchasing system
Host:Zhu Hengpeng--Professor, Director of public policy research centre at Institute of Economics of CASS
Speaker:Fu Hongpeng--Professor, Ph.D, Director of Department of Medcines Policy, China Health Development & Research Center(CHDRC)
Panelist 1:Wei Juncai--Vice President of Kelun Pharma
Panelist 2:Chen Chuan--Founder of HuaKang Healthcare Consulting Inc

Session 2：R&D Technology Forum
13:30-14:15Panel: Optimizing design for new drug clinical experiment
Host:Wang Yinxiang--CEO and Chief Scientist Officer (CSO) of Zhejiang Beta Pharma, Inc.( ZBPI)
Speaker:Shein-Chung Chow--Ph.D, Professor at the Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina and Founding Director of Global Clinical Trial and Research Center
Panelist 1：He Wei--Ph.D, General Manager and director of DTRM Biopharma
Panelist 2：Gai Wenlin--Ph.D, Deputy director for Cell engineering research and development center, Chinese Academy of Medical Science&Peking Union Medical College
14:20-15:05Panel: Data management for new drug clinical experiment
Host:Liu Chuan--PhD,Director of China Development of Medidata Solutions Worldwide
Speaker:Huang Qin--Vice minister of Biostatistics Faculty of Evaluation Center in CFDA
Panelist 1:Shi Yuankai—Cancer Institute & Hospital, Chinese Academy of Medical Sciences (CAMS)
Panelsit 2:Li Wei--Director of Medical Research & Biometrics Center，National Center for Cardiovascular Diseases
15:05-15:15Tea Break
15:15-16:00Panel：Drug innovation & Intellectual property protection
Host:Cui Guobin--Director of Intellectual Property Center in Tsinghua University School of Law
Speaker:Zhang Qingkui--Professor, former minister of Biological Examination Department，Reexamination Board of the Chinese State Intellectual Property Office
Panelist 1:Jiang Hui--Director of general affair division, Pharmaceutical and Biological Invention Examination Department of the State Intellectual Property Office
Panelist 2:Michael Minney--Senior Director, Global Health Access & International Public Affairs, Celgene
Panelist 3:Xue Yunli--Vice President of Luye Pharmaceutical Company
Panelist 4:Tang Weijie--CCPIT Patent and Trademark Law Office
16:05-16:50Panel: Introduction on Biosimilar related policies in EU/US
Host:Su Ling--Immediate Past President of Drug Information Association (DIA)
Speaker:Eric CHI--Ph.D, Head of Statistics and Statistical Programming, Biosimilar Division of Amgen Inc
Panelist 1:Fu Daotian--Executive Vice President of Livzon MabPharm, Inc
Panelist 2:Wu Chenbing—President of R&D Biotechnology Institute of Shanghai CP Guojian Pharmaceutical Co. Ltd.

Session 3：Business Collaboration Bridge –Introduction & Conversation
13:30-13:40 Opening Address
13:40-15:00 Introductions by each delegation China Medical City Indian Confederation Industry Invest in Denmark Medical Research Council Technology WorlDiscoveries of University of Western Ontario
15:00-17:00 “One on One” Business Dialogue